Okay, let's tackle this question about losartan versus enalapril. The user wants a detailed explanation for an MCQ where the correct answer is losartan's advantage over enalapril. First, I need to recall the core concepts. Both are antihypertensives: losartan is an ARB (angiotensin II receptor blocker), and enalapril is an ACE inhibitor.

The core concept here is comparing these two drug classes. The question is about an advantage of losartan. Common advantages of ARBs over ACE inhibitors include fewer side effects like cough and angioedema. Also, ARBs don't affect bradykinin levels as much as ACE inhibitors, which might reduce the incidence of dry cough.

Now, the correct answer is likely related to the absence of a dry cough. Let me verify. ACE inhibitors like enalapril cause dry cough in up to 10% of patients due to increased bradykinin and substance P. Losartan, by blocking the AT1 receptor, doesn't affect bradykinin breakdown, so the cough is less common. So the advantage is the lower incidence of cough.

Next, the incorrect options need to be addressed. Common wrong options might involve other side effects or mechanisms. For example, if an option says "reduces aldosterone more," that's incorrect because both classes reduce aldosterone. Another wrong option could be "causes more hyperkalemia," but actually, both can cause hyperkalemia, though maybe ARBs are slightly more likely. Another incorrect point might be "has diuretic effect," but neither are diuretics. Or maybe "better for heart failure," but both are used in heart failure, though ACE inhibitors are first-line.

Clinical pearl: Remember that ARBs are often used when patients can't tolerate ACE inhibitors due to cough. So, the key is the cough side effect.

Putting it all together in the required sections. Make sure each part is concise and within the character limit. Check for medical accuracy and clarity. Avoid markdown except for the specified sections. Use bold for key terms. Let me structure each part step by step.

**Core Concept**
This question compares angiotensin II receptor blockers (ARBs) like losartan to angiotensin-converting enzyme (ACE) inhibitors like enalapril. The key distinction lies in their mechanisms of action and side effect profiles, particularly regarding bradykinin metabolism and cough incidence.

**Why the Correct Answer is Right**
Losartan blocks angiotensin II at the AT₁ receptor, while enalapril inhibits angiotensin-converting enzyme. Enalapril increases bradykinin levels by blocking its degradation, leading to a **dry cough** in 5–10% of patients. Losartan does not affect bradykinin levels, making it a better choice for patients who develop a cough with ACE inhibitors. This is a well-documented advantage of ARBs over ACE inhibitors.

**Why Each Wrong Option is Incorrect**
**Option A:** "Reduces aldosterone secretion more effectively" – Both drug classes lower aldosterone via angiotensin II inhibition; no class-specific superiority here.
**Option B:** "Causes less hyperkalemia" – ARBs like losartan are associated with *higher*

✓ Correct Answer: D. Less incidence of angioedema